InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
44%
T+90 mean return
-0.3%
Across 9 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Yanai Shlomo, Director. Insider active across 3 companies, notably Amneal Pharmaceuticals, Inc.. Cumulatively, 16 filings have been published. History available since 5 May 2021. The latest transaction was filed on 7 May 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations16 total
1,002 shares@ US$174.8216.6% of flowCommon StockSEC:0001413329-25-000115:0
40,258 sharesClass A Common StockSEC:0001628280-25-024000:0
76,453 sharesClass A Common StockSEC:0001628280-24-023244:0
1,789 shares@ US$97.8417.5% of flowCommon StockSEC:0001413329-24-000120:0
80,128 sharesClass A Common StockSEC:0001209191-23-028732:0
1,812 shares@ US$96.5817.0% of flowCommon StockSEC:0001413329-23-000145:0
35,406 sharesClass A Common StockSEC:0001209191-22-028165:0
1,759 shares@ US$99.530.0001% mcap36.1% of flowCommon StockSEC:0001182489-22-000037:0
6,973 sharesCommon Stock, par value $0.01 per shareSEC:0001045309-21-000099:0
6,973 sharesCommon Stock, par value $0.01 per shareSEC:0001045309-21-000099
1,683 shares0Common Stock, par value $0.01 per shareSEC:0001045309-21-000068:0
1,683 shares0Common Stock, par value $0.01 per shareSEC:0001045309-21-000068
1,839 shares@ US$95.17531.9% of flowCommon StockSEC:0001182489-21-000102
46,218 sharesClass A Common StockSEC:0001209191-21-030815:0
1,839 shares@ US$95.1750.0001% mcap31.9% of flowCommon StockSEC:0001182489-21-000102:0
46,218 sharesClass A Common StockSEC:0001209191-21-030815
16 of 16 declarations
About Yanai Shlomo
Shlomo Yanai is a Board Member at Amneal Pharmaceuticals, Inc., Philip Morris International Inc., and W R Grace & Co. In this role, he contributes to the governance of these companies, bringing his expertise to the board. These companies operate in various sectors, ranging from pharmaceuticals to chemicals. Mr. Yanai's experience in these areas is valuable for guiding strategic decisions.
